Skip to main content
Clinical Trials/TCTR20190311001
TCTR20190311001
Recruiting
Phase 4

Randomized controlled trial of a comparison between ritonavir-boosted atazanavir with tenofovir plus emtricitabine versus rilpivirine with tenofovir plus emtricitabine in occupational post-exposure prophylaxis for HIV infection

King Chulalongkorn Memorial Hospital0 sites82 target enrollmentMarch 11, 2019

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Occupational post&#45
Sponsor
King Chulalongkorn Memorial Hospital
Enrollment
82
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2019
End Date
February 19, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \>18\-year\-old of age
  • occupational exposure to HIV less than 72 hours

Exclusion Criteria

  • non\-occupational exposure to HIV
  • allergic to study drugs
  • HIV\-negative source

Outcomes

Primary Outcomes

Not specified

Similar Trials